Summary Statistics:
ASD Reports: 18
Recent Reports: 4
Annotated variants: 15
Associated CNVs: 8
Evidence score: 2
Gene Score: 5
Relevance to Autism
Rare variants in the ERBB4 gene have been identified with autism (Pinto et al., 2010) as well as schizophrenia (Walsh et al., 2008).
Molecular Function
A transmembrane receptor tyrosine kinase that regulates cell proliferation and differentiation
References
Primary
Functional impact of global rare copy number variation in autism spectrum disorders.
ASD
Support
Genome-wide characteristics of de novo mutations in autism
ASD
Support
A new single gene deletion on 2q34: ERBB4 is associated with intellectual disability.
ID
Support
Integrating de novo and inherited variants in 42
ASD
Support
Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder.
ASD
Support
Developmental Disruption of Erbb4 in Pet1+ Neurons Impairs Serotonergic Sub-System Connectivity and Memory Formation
Support
A discovery resource of rare copy number variations in individuals with autism spectrum disorder.
ASD
Support
Both rare and common genetic variants contribute to autism in the Faroe Islands.
ASD
Support
Whole-Genome Sequencing of Cytogenetically Balanced Chromosome Translocations Identifies Potentially Pathological Gene Disruptions and Highlights t...
ASD, ID, epilepsy/seizures
Support
Mutations in Human Accelerated Regions Disrupt Cognition and Social Behavior.
ASD
Highly Cited
Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor.
Highly Cited
Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases.
Highly Cited
A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling.
Recent Recommendation
Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling.
Recent Recommendation
Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury.
Recent Recommendation
Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system.
Recent Recommendation
Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia.
SCZ
GEN081R001
copy_number_loss
GEN081R002
copy_number_loss
GEN081R003
copy_number_loss
GEN081R004
copy_number_loss
GEN081R005
copy_number_loss
GEN081R006
copy_number_loss
Familial
Maternal
Unknown
GEN081R007
copy_number_loss
Unknown
Unknown
GEN081R008
copy_number_loss
Familial
Maternal
Simplex
GEN081R009
copy_number_loss
De novo
GEN081R010
intron_variant
c.2487+50157A>G
De novo
Simplex
GEN081R011
intron_variant
c.421+38882T>C
Unknown
GEN081R012
translocation
De novo
GEN081R013
frameshift_variant
c.2743_2744insGTTCCCATATAGTAACTCCTATATTGGAGAAAAA
p.Thr915SerfsTer19
Familial
Paternal
Simplex
GEN081R014
synonymous_variant
c.1938A>G
p.Gln646%3D
De novo
GEN081R015
missense_variant
c.328C>G
p.Leu110Val
De novo
No Common Variants Available
2
Deletion-Duplication
25
Summary Statistics:
# of Reports: 3
# of Models: 2
Model Summary
First plausible link between NRG-1/ErbB4 signaling and rhythmic network activity that may be altered in persons with schizophrenia.
References
Primary
Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia.
Additional
Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice.
Additional
Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons.
Model Type:
Genetic
Model Genotype:
Homozygous
Mutation:
Transgenic mice expressing human ErbB4 cDNA under the control of the cardiac-specific alpha-MHC promoter in knockout mice.
Allele Type: Targeted (Transgenic)
Strain of Origin: C57BL/6
Genetic Background: Not Specified
ES Cell Line: Not Specified
Mutant ES Cell Line: Not Specified
Model Source: Not Specified
Model Type:
Genetic
Model Genotype:
Homozygous
Mutation:
Conditional deletion of exon 2 of ErbB4 gene using Pvalb-cre, in parvalbumin expressing interneurons
Allele Type: Conditional loss-of-function
Strain of Origin: Not Specified
Genetic Background: Not Specified
ES Cell Line: R1
Mutant ES Cell Line: Not Specified
Model Source: Not Specified
Neuronal number: purkinje cells1
Decreased
View More
Description: Decreased numerical density of parvalbumin (pv)-positive neurons in cornu ammonis
Exp Paradigm: Double immunofluorescene analysis using anti-parvalbumin and anti-erbb4 antibodies of hippocampal slices
Immunohistochemistry
9-12 weeks
Neuronal number: interneurons2
Decreased
View More
Description: Decreased density of cck-positive cells in all areas of the hippocampus
Exp Paradigm: Cck
Immunohistochemistry
12-16 weeks
Neuronal number: interneurons2
Decreased
View More
Description: Decreased number of gabaergic cells demonstrated by decrease in gad67-immunoreactivity throught the hippocampus
Exp Paradigm: Gad67
Immunohistochemistry
12-16 weeks
Neuronal number: interneurons2
Decreased
View More
Description: Decreased neuronal density of nnos-positive cells across the dorsoventral axis, dentate gyrus, and subiculum of the hippocampus
Exp Paradigm: Nnos
Immunohistochemistry
12-16 weeks
Neuronal number: interneurons2
Decreased
View More
Description: Decreased density of parvalbumin (pv) positive cells in the hippocampus
Exp Paradigm: Pv
Immunohistochemistry
12-16 weeks
Decreased
View More
Description: Decreased gamma oscillation power in hippocampal slices in response to nrg-1beta
Exp Paradigm: Extracellular field recordings in stratum pyramidale of ca3 of hippocampal slices after nrg1beta administration
Field potential recordings
9-12 weeks
Decreased
View More
Description: Decreased gamma oscillation power in hippocampal slices in response to kainate
Exp Paradigm: Extracellular field recordings in stratum pyramidale of ca3 of hippocampal slices after kainate administration
Field potential recordings
9-12 weeks
No change
Immunohistochemistry
9-12 weeks
Neuronal number: purkinje cells2
No change
Immunohistochemistry
12-16 weeks
Not Reported:
Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Molecular profile, Motor phenotype, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior
General locomotor activity1
Increased
View More
Description: Increased locomotor activity demonstrating hyperactivity
Exp Paradigm: Open field test
Open field test
Unreported
Decreased
View More
Description: Decreased attenuation of spontaenous firing rate of pyramidal neurons in response to nrg1
Exp Paradigm: NA
NA
Unreported
Decreased
View More
Description: Decreased amplitude of evoked inhibitory postsynaptic currents
Exp Paradigm: NA
NA
Unreported
Decreased
View More
Description: Decreased pre-pulse inhibition of auditory evoked startle stimulus
Exp Paradigm: Pre-pulse inhibition of auditory evoked startle with three levels of pre-pulse
Prepulse inhibition
Unreported
Increased
View More
Description: Increased pre-pulse inhibition after administration of diazepam
Exp Paradigm: Pre-pulse inhibition of auditory evoked startle with three levels of pre-pulse after administration of diazepam (3 mg/kg)
Prepulse inhibition
Unreported
Decreased
View More
Description: Decreased working memory demonstrated by increased number of total errors
Exp Paradigm: Performance on an automated radial arm maze
Radial maze test
Unreported
No change
General observations
Unreported
Not Reported:
Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Maternal behavior, Molecular profile, Neuroanatomy / ultrastructure / cytoarchitecture, Physiological parameters, Repetitive behavior, Seizure, Social behavior
Summary Statistics:
Total Interactions: 2
Total Publications: 2
Show all nodes
Hide non-ASD